Alcohol. Ethanol Highlands Parkway, Suite 100 Smyrna, GA 30082

Size: px
Start display at page:

Download "Alcohol. Ethanol Highlands Parkway, Suite 100 Smyrna, GA 30082"

Transcription

1 Alcohol The alcohol of interest is ethanol. Ethanol has a sedative effect in the brain. Ethanol intoxication symptoms include blurred vision, slurred speech, poor coordination and difficulty thinking depending on the levels. Ethanol is primarily metabolized into acetaldehyde by alcohol dehydrogenase. Upon the accumulation of acetaldehyde, aldehyde dehydrogenase metabolizes the acetaldehyde into acetic acid. Acetic acid is then transformed to acetyl-coa that is used in the Kreb s cycle (the energy producing cycle in the cell). To a much lesser extent, an enzyme known as UGT transforms ethanol to ethylglucuronide (EtG) and an enzyme known as SULT transforms ethanol to ethylsulfate (EtS). Ethanol consumption has been found to cause dependence and tolerance can be rapidly acquired. EIA screening is not available for the metabolites of ethanol at Castle Medical. chromatography to separate substances in the sample using a mixture of solvents and mass spectrometry fragmentation pattern for further identification. The result is obtained from both the chromatography and mass spectrometry to produce a unique identification pattern that indicates the type and amount of the drug present in the sample. Ethanol detection is achieved mainly through the metabolites EtG and EtS. The presence of EtG and EtS is a good indication of exposure to ethanol. List of Alcohol of Interest Ethanol (ethylglucuronide and ethylsulfate). Urine Ethanol

2 Anticonvulsants The class of anticonvulsants refers to the group of substances that treat epileptic seizures. While anticonvulsants exist as a separate class, it is common to see overlap with drugs between this class and other classes as a result it contains substances that are structurally very different. It is common to see anticonvulsants used to treat neuropathic pain. The potency and acquired dependence on the drug varies from drug to drug in this class. : EIA screening is not available for the anticonvulsants of interest at Castle Medical. : identification. The result is obtained from both the chromatography and mass spectrometry to produce a unique identification pattern that Most anticonvulsants undergo metabolism by the family of Cytochrome P450 (CYP) enzymes in the human body. It is common to detect metabolites and to a lesser extent parent drugs in urine specimen. However, it is likely to detect parent drugs and to a lesser extent metabolites in saliva and blood specimens. The presence of parent drugs and/or metabolites in all matrices is a good indication of exposure to a substance. Gabapentin is not metabolized and consequently only the parent drug is reported. Similarly, Pregabalin undergoes negligible metabolism and only the parent drug is reported. List of Anticonvulsants of Interest Gabapentin, Pregabalin. Gabapentin

3 Antidepressants The class of antidepressants refers to the group of substances that treat a range of psychological disorders including depression, OCD, sleeping disorder, manic-depressive disorder, etc. Antidepressants can be divided further into subclasses to include: tricyclic antidepressants (TCA s), selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), and monoamine oxidase inhibitors (MAOIs). Although the chemical structure may vary across subclasses, they all correct for an imbalance in neurotransmitters in the brain primarily by inhibiting the reuptake. TCA s such amitriptyline and MAOIs such as isoniazid were the earliest antidepressants to be used for treatment. The class then grew to include SSRIs such as sertraline and SNRIs such as venlafaxine that are commonly referred to as the second generation antidepressants. SNRIs are sometime classified as third generation antidepressants. Cyclobenzaprine, while structurally similar to tricyclic antidepressants, is a muscle relaxer. It is not prescribed for depression or other psychological disorders. The potency and acquired dependence on the drug varies from drug to drug in this class. : The screening is performed using an immunoassay-based technique. The technique uses class-specific antibodies and utilizes absorbance for detection. The antibodies have varying cross-reactivity with different antidepressants. The immunoassay method at Castle Medical targets TCA s. Other Over-the-Counter (OTC) medications and/or substances may also cross-react. : identification. The result is obtained from both the chromatography and mass spectrometry to produce a unique identification pattern that Antidepressants undergo metabolism by the family of Cytochrome P450 (CYP) enzymes in the human body. It is common to detect metabolites and to a lesser extent parent drugs in urine specimen. However, it is likely to detect parent drugs and to a lesser extent metabolites in saliva and blood specimens. The presence of parent drugs and/or metabolites in all matrices is a good indication of exposure to a substance. sure to a substance. Amitriptyline List of Antidepressants of Interest Amitriptyline, nortriptyline, imipramine, desipramine, sertraline, cyclobenzaprine.

4 Barbiturates The class of barbiturates refers to the group of substances that are typically used as hypnotics and/or anticonvulsants by depressing the nervous system. Barbiturates can be very short-, short, intermediate, and long-acting. The onset of action mirrors the duration of action of barbiturates. Very short-acting barbiturates have a rapid onset and a very short duration of action. Long-acting barbiturates have a delayed onset of action and a long duration that could potentially last for days. The potency and acquired dependence on the drug varies from drug to drug in this class. The screening is performed using an immunoassay-based technique. The technique uses class-specific antibodies and utilizes absorbance for detection. The antibodies have varying cross-reactivity across all barbiturates. The immunoassay method at Castle Medical targets the barbiturate class collectively. Other Over-the-Counter (OTC) medications and/or substances may also cross-react. chromatography to separate substances in the sample using a mixture of solvents and mass spectrometry fragmentation pattern for further identification. The result is obtained from both the chromatography and mass spectrometry to produce a unique identification pattern that indicates the type and amount of the drug present in the sample. Barbiturates undergo metabolism by the family of Cytochrome P450 (CYP) enzymes in the human body. It is common to detect metabolites and to a lesser extent parent drugs in urine specimen. However, it is likely to detect parent drugs and to a lesser extent metabolites in saliva and blood specimens. The presence of parent drugs and/or metabolites in all matrices is a good indication of exposure to a substance. List of Barbiturates of Interest Butalbital, phenobarbital. Butalbital

5 Bath Salts Bath Salts refers to the group of substances that produce a stimulatory effect on the nervous system. The chemical structure is very similar to amphetamine with modification at certain points in the structure. They are a variation of the substance Cathinone, a major constituent of the shrub Catha edulis (khat) and as a result sometimes referred to as Designer Cathinones. They are primarily abused for their stimulatory effects however some also produce hallucinogenic effects. Bath Salts are not used to treat any ailment and as a result have no accepted medical use. They are typically sold as a powder marketed as not for human consumption and have no connection with salts used in bathtubs. The potency and acquired dependence on the drug varies from drug to drug in this class. CROSS-REACTIVITY NEEDS TO BE TESTED. PLEASE PROVIDE INPUT IF IT REACTS WITH AMPHETAMINE ON OLYMPUS. chromatography to separate substances in the sample using a mixture of solvents and mass spectrometry fragmentation pattern for further identification. The result is obtained from both the chromatography and mass spectrometry to produce a unique identification pattern that indicates the type and amount of the drug present in the sample. Bath Salts undergo metabolism by the family of Cytochrome P450 (CYP) enzymes in the human body. It is common to detect metabolites and to a lesser extent parent drugs in urine specimen. However, it is likely to detect parent drugs and to a lesser extent metabolites in saliva and blood specimens. The presence of parent drugs and/or metabolites in all matrices is a good indication of exposure to a substance. List of Bath Salts of Interest 3,4-methylenedioxypyrovalerone (MDPV), mephedrone, methylone, α-pyrrolidinopentiophenone (α-pvp). Urine, Blood Cathinone

6 Benzodiazepines The class of benzodiazepines refers to the group of substances that decrease the excitability of neurons in the brain. As a result, they are primarily used as anticonvulsants, anti-anxiety, muscle relaxants, and to treat insomnia. Benzodiazepines can be short-, intermediate-, and long-acting. Short-acting benzodiazepine, such as midazolam, are typically used to treat insomnia because of their sedative-hypnotic effect. Long-acting benzodiazepines, such as diazepam, are typically used to treat anxiety. The potency and acquired dependence on the drug varies from drug to drug in this class. : The screening is performed using an immunoassay-based technique. The technique uses class-specific antibodies and utilizes absorbance for detection. The antibodies have varying cross-reactivity with different benzodiazepines for the method used at Castle Medical. Other Over-the-Counter (OTC) medications and/or substances may also cross-react for example sertraline (Zoloft), an antidepressant. : identification. The result is obtained from both the chromatography and mass spectrometry to produce a unique identification pattern that Benzodiazepines undergo metabolism by the family of Cytochrome P450 (CYP) enzymes in the human body. It is common to detect metabolites and to a lesser extent parent drugs in urine specimen. However, it is likely to detect parent drugs and to a lesser extent metabolites in saliva and blood specimens. The presence of parent drugs and/or metabolites in all matrices is a good indication of exposure to a substance. List of Benzodiazepines of Interest Alprazolam, clonazepam, diazepam, nordiazepam, oxazepam, temazepam, lorazepam, midazolam, triazolam, flunitrazepam, flurazepam, chlordiazepoxide. Diazepam

7 Cannabinoids The class of cannabinoids refers to the group of substances that bind to certain receptors in the brain that represses the release of neurotransmitters. Their mechanism of action results in some mood and perceptual alterations. Cannabinoids have been commonly prescribed to treat anorexia, decrease nausea and vomiting associated with chemotherapy, and to treat glaucoma. The most prevalent cannabinoid is 9-tetrahydrocannabinol (THC), a main constituent in cannabis. Synthetic variations of THC have been formulated in an attempt to circumvent the illegalization of THC and provide safer alternatives even though it is well understood that they are not safer alternatives. The formulations have been modified with chemical additives and plant material to provide psychoactive effects similar to marijuana. The formulations are commonly referred to as K2/Spice and typically marketed as incense that is not for human consumption. The potency and acquired dependence on the drug varies from drug to drug in this class. The screening is performed using an immunoassay-based technique. The technique uses class-specific antibodies and utilizes absorbance for detection. The antibodies have varying cross-reactivity across all cannabinoid derivatives. The immunoassay method at Castle Medical targets the cannabinoid structure with varying interactions with Over-the-Counter (OTC) medications and/or substances. identification. The result is obtained from both the chromatography and mass spectrometry to produce a unique identification pattern that Cannabinoids undergo metabolism by the family of Cytochrome P450 (CYP) enzymes in the human body. It is common to detect metabolites and to a lesser extent parent drugs in urine specimen. However, it is likely to detect parent drugs and to a lesser extent metabolites in saliva and blood specimens. The presence of parent drugs and/or metabolites in all matrices is a good indication of exposure to a substance. THC List of Cannabinoids of Interest Cannabinoid panel: THC (and the metabolite 11-nor-9-Carboxy-THC (THCA)). K2/Spice panel: AM 1248, AM 2201 OH Pentyl metabolite, JWH-018 (and the metabolites JWH-018 OH Pentyl and JWH Pentanoic Acid), JWH-073 (and the JWH-073 Butonic Acid and JWH-073 OH Butyl), JWH-250 OH Pentyl metabolite, XLR-11, UR-144.

8 Dissociatives The class of dissociative hallucinogens refers to the group of substances that typically produce a feeling of detachment from the body and the surrounding primarily through sensory deprivation and often induces hallucinations. The dissociation can also produce an analgesic effect. Two common dissociatives include Ketamine and Phencyclidine (PCP). The potency and acquired dependence on the drug varies from drug to drug in this class. EIA screening is not available for PCP at Castle Medical. identification. The result is obtained from both the chromatography and mass spectrometry to produce a unique identification pattern that Most dissociatives undergo metabolism by the family of Cytochrome P450 (CYP) enzymes in the human body. It is common to detect metabolites and to a lesser extent parent drugs in urine specimen. However, it is likely to detect parent drugs and to a lesser extent metabolites in saliva and blood specimens. The presence of parent drugs and/or metabolites in all matrices is a good indication of exposure to a substance. List of Dissociatives of Interest PCP. Phencyclidine

9 Nicotine Nicotine is a constituent of tobacco plants and consequently cigarettes along with Anabasine. It produces a sensation of relaxation and euphoria upon exposure. It is considered highly habit-forming and rapidly causes addiction. Nicotine treatments such as nicotine patches have been developed to help quit cigarette smoking. EIA screening is not available for nicotine and its metabolites at Castle Medical. chromatography to separate substances in the sample using a mixture of solvents and mass spectrometry fragmentation pattern for further identification. The result is obtained from both the chromatography and mass spectrometry to produce a unique identification pattern that indicates the type and amount of the drug present in the sample. Nicotine undergoes metabolism by the family of Cytochrome P450 (CYP) enzymes in the human body to form Continine along with other metabolites. It is common to detect metabolites and to a lesser extent parent drugs in urine specimen. There are no known metabolites for Anabasine. The presence of parent drugs and/or metabolites in all matrices is a good indication of exposure to a substance. List of Nicotine of Interest Nicotine, Cotinine, Anabasine. Urine Nicotine

10 Opiates Opioids The class of opiates and opioids refers to the group of substances that produce analgesic effects in the body. Opiates refer to the group of chemicals present naturally in the poppy plant such as morphine and codeine. Opioids refer to the group of chemicals either synthetic or semi-synthetic such as oxycodone and hydrocodone that behave similar to opiates in the body producing similar effects. This class of drugs is typically used for pain treatment. Carisoprodol however has been used primarily as a muscle relaxant. The potency and acquired dependence on the drug varies from drug to drug in this class. : The screening is performed using an immunoassay-based technique. The technique uses class-specific antibodies and utilizes absorbance for detection. The antibodies have varying cross-reactivity with different opiates/opioids. The immunoassay method at Castle Medical targets all opiates. The method also screens selectively for oxycodone with some cross-reactivity towards other opiates. Other Over-the-Counter (OTC) medications and/or substances may also cross-react. : identification. The result is obtained from both the chromatography and mass spectrometry to produce a unique identification pattern that Opiates/Opioids undergo metabolism by the family of Cytochrome P450 (CYP) enzymes in the human body. It is common to detect metabolites and to a lesser extent parent drugs in urine specimen. However, it is likely to detect parent drugs and to a lesser extent metabolites in saliva and blood specimens. The presence of parent drugs and/or metabolites in all matrices is a good indication of exposure to a substance. Heroin presence is evaluated by detecting the metabolites 6-monoacetylmorphine (6-MAM) and morphine and not the parent drug heroin. Morphine List of Opiates/Opioids of Interest Morphine, codeine, hydrocodone, hydromorphone, dihydrocodeine, naloxone, buprenorphine, norbuprenorphine, oxycodone, oxymorphone, 6-MAM, tramadol, O-desmethyltramadol, tapentadol, Destapentadol, fentanyl, norfentanyl, carisoprodol, meprobamate, methadone, EDDP, meperidine, normeperidine, propoxyphene, norpropoxyphene, dextrorphan, dextromethorphan.

11 Stimulants The class of stimulants refers to the group of substances that produce a stimulatory effect on the nervous system. A common example of a stimulant is amphetamine. Stimulants are typically used to treat disorders such as ADD, ADHD, obesity, and narcolepsy. Many stimulants such as amphetamine and methamphetamine have chiral carbons dividing them into d- and l- stereoisomers of the same drug. The d- isomer is typically more active and is sometime used to refer to illicit use of methamphetamine based on the d/l isomer ratio. Some stimulants may have additional hallucinogenic effects such as MDMA, MDEA, and MDA. The potency and acquired dependence on the drug varies from drug to drug in this class. : The screening is performed using an immunoassay-based technique. The technique uses class-specific antibodies and utilizes absorbance for detection. The antibodies have varying cross-reactivity with different stimulants particularly phenethylamine derivatives. The immunoassay method at Castle Medical targets amphetamine with some cross-reactivity towards phenethylamine derivatives. Other Over-the-Counter (OTC) medications and/or substances may also cross-react. : identification. The result is obtained from both the chromatography and mass spectrometry to produce a unique identification pattern that Stimulants undergo metabolism by the family of Cytochrome P450 (CYP) enzymes in the human body. It is common to detect metabolites and to a lesser extent parent drugs in urine specimen. However, it is likely to detect parent drugs and to a lesser extent metabolites in saliva and blood specimens. The presence of parent drugs and/or metabolites in all matrices is a good indication of exposure to a substance. Amphetamine List of Stimulants of Interest Comprehensive panel Amphetamine, methamphetamine, MDMA (3,4-methylenedioxymethamphetamine), MDA (3,4-methylenedioxyamphetamine), cocaine (and the metabolites benzoylecgonine and cocaethylene), methylphenidate (and the metabolite ritalinic acid). Expanded amphetamine panel: MDEA (3,4-methylenedioxyethylamphetamine), phendimetrazine, ephedrine, phentermine, PPA phenylpropanolamine.

12 Z-Drugs Z-drugs refer to a group of three drugs (zolpidem, zaleplon, and zopiclone/ezopiclone) that are typically used to treat insomnia. They are categorized as nonbenzodiazepine hypnotics. Though their activity in the brain is similar to that of benzodiazepines by targeting benzodiazpine receptors, they are structurally very different from benzodiazepines. The potency and acquired dependence on the drug varies from drug to drug. The decision to prescribe the Z-drugs over benzodiazepines for insomnia is based on the decreased probability of dependence, however long-term use of the Z-drugs can still result in dependence and/or addiction. Tolerance to them is thought to be rapidly acquired. EIA Screening is not available for the Z-drugs of interest at Castle Medical. chromatography to separate substances in the sample using a mixture of solvents and mass spectrometry fragmentation pattern for further identification. The result is obtained from both the chromatography and mass spectrometry to produce a unique identification pattern that indicates the type and amount of the drug present in the sample. Z-drugs undergo metabolism by the family of Cytochrome P450 (CYP) enzymes in the human body. It is common to detect metabolites and to a lesser extent parent drugs in urine specimen. In fact, Z-drugs undergo extensive metabolism to their metabolites. In contrast, it is likely to detect parent drugs and to a lesser extent metabolites in saliva and blood specimens. The presence of parent drugs and/or metabolites in all matrices is a good indication of exposure to a substance. List of Z-Drugs of Interest Zaleplon, zolpidem (and the phenolic metabolite zolpidem-cooh), zopiclone/ezopiclone. Zolpidem

LCMS-8050 Drugs of Abuse: 113 Analytes with Polarity Switching

LCMS-8050 Drugs of Abuse: 113 Analytes with Polarity Switching Liquid Chromatography Mass Spectrometry SSI-LCMS-8 LCMS-8 Drugs of Abuse: Analytes with Polarity Switching LCMS-8 Summary Seventy six analytes and their internal standards are described below. Multiple

More information

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D Director: David J.

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D Director: David J. Drug Adherence Assessment Report Prescribed Medications: NO MEDICATION LIST PROVIDED CONSISTENT RESULTS - REPORTED MEDICATION DETECTED (PARENT DRUG AND/OR METABOLITE) REPORTED PRESCRIPTION FLAG ANTICIPATED

More information

1/27/ New Release, Quest Diagnostics Nichols Institute, Valencia

1/27/ New Release, Quest Diagnostics Nichols Institute, Valencia NEW TESTS Please Note: Not all test codes assigned to each assay are listed in the table of contents. Please refer to the complete listing on the page numbers indicated. Test Code Test Name Effective Date

More information

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D years

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D years Drug Adherence Assessment Report CleanAssure TM (DRIED BLOOD SPOT): Detection Range see NOTES. Prescribed Medications: HYDROMORPHONE (DILAUDID, EXALGO), CYCLOBENZAPRINE (FLEXERIL), METHADONE (METHADOSE),

More information

Pain Management and Compliance Toxicology. Greg Jellick, MSFS, D-ABFT-FT Technical Director Quality Toxicology San Antonio, TX

Pain Management and Compliance Toxicology. Greg Jellick, MSFS, D-ABFT-FT Technical Director Quality Toxicology San Antonio, TX Pain Management and Compliance Toxicology Greg Jellick, MSFS, D-ABFT-FT Technical Director Quality Toxicology San Antonio, TX Prescription Drug Abuse: A National Problem Prescription drug abuse is a growing

More information

September HCMC Toxicology Transition: Additional information and Frequently Asked Questions

September HCMC Toxicology Transition: Additional information and Frequently Asked Questions September 2016 HCMC Toxicology Transition: Additional information and Frequently Asked Questions Many clinicians have asked for more information about the Urine Drug Compliance Analysis (LAB8742) switch

More information

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D years

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D years Drug Adherence Assessment Report CleanAssure TM (DRIED BLOOD SPOT): Detection Range see NOTES. Prescribed Medications: NO MEDICATION LIST PROVIDED CONSISTENT RESULTS - MEDICATION DETECTED (PARENT DRUG

More information

nextgen precision Test Report

nextgen precision Test Report nextgen precision TM Test Report SUMMARY OF PRECISION S NEXTGEN TEST REPORT In an effort to provide as much clinical insight as possible to our providers, we created our comprehensive NextGen Precision

More information

Forensic Toxicology Scope of Testing and Detection Limits

Forensic Toxicology Scope of Testing and Detection Limits Forensic Toxicology Scope of Testing and Detection Limits Table of Contents QUALITATIVE ANALYSES... 2 Volatile Screen by GC/FID... 2 Carbon Monoxide by Microdiffusion... 2 Ethylene Glycol by GC/MS... 2

More information

The Drug Testing Process. Employer or Practice

The Drug Testing Process. Employer or Practice Disclosures Clinical Professor, Jefferson Medical College BOD MROCC [Medical Review Officer Certification Council] BOD National Sleep Foundation BOD POEMS [Pennsylvania Occupational & Environmental Medicine

More information

Using Liquid Chromatography Tandem Mass Spectrometry Urine Drug Testing to Identify Licit and Illicit Drug-Use in a Community-based Patient Population

Using Liquid Chromatography Tandem Mass Spectrometry Urine Drug Testing to Identify Licit and Illicit Drug-Use in a Community-based Patient Population Using Liquid Chromatography Tandem Mass Spectrometry Urine Drug Testing to Identify Licit and Illicit Drug-Use in a Community-based Patient Population Adam S. Ptolemy 1, Colleen Murray 2, Edward Dunn 3,

More information

Urine Opioid Dependency Panel (UODP) 1

Urine Opioid Dependency Panel (UODP) 1 Drug Testing Panels Urine Opioid Dependency Panel (UODP) 1 Amphetamines Amphetamine Methamphetamine Methylenedioxyamphetamine Adderall, Dexedrine, Vyvanse, Lisdexamfetamine (Speed, Bennies, Crystal Meth,

More information

Effective Date: Approved by: Laboratory Executive Director, Ed Hughes (electronic signature)

Effective Date: Approved by: Laboratory Executive Director, Ed Hughes (electronic signature) 1 Policy #: 803 (PLH-803-02) Effective Date: NA Reviewed Date: 4/11/2008 Subject: URINE DRUG SCREENS Approved by: Laboratory Executive Director, Ed Hughes (electronic signature) Approved by: Laboratory

More information

Physician s Reference for Urine and Blood Drug Testing and Interpretation

Physician s Reference for Urine and Blood Drug Testing and Interpretation Physician s Reference for Urine and Blood Drug Testing and Interpretation DETECTIMED PANEL Urine (test code 70195) Screen Confirmation Screen Confirmation Alcohol Ethanol Amphetamines Amphetamine Methamphetamine

More information

Rapid and Sensitive Analysis of a 93-Compound Forensic Panel in Urine using the QTRAP /Triple Quad 4500 LC- MS/MS System

Rapid and Sensitive Analysis of a 93-Compound Forensic Panel in Urine using the QTRAP /Triple Quad 4500 LC- MS/MS System Rapid and Sensitive Analysis of a 93-Compound Forensic Panel in Urine using the QTRAP /Triple Quad 4500 LC- MS/MS System Xiang He, 1 Casey Burrows 1, Matthew Noestheden 2, Michael Jarvis, 2 Adrian Taylor,

More information

Drug Adherence Assessment Report

Drug Adherence Assessment Report Prescribed Medications: Drug Adherence Assessment Report FENTANYL, OXYCODONE CONSISTENT RESULTS - REPORTED MEDICATION DETECTED (PARENT DRUG AND/OR METABOLITE) REPORTED ANTICIPATED TEST PRESCRIPTION (S)

More information

Get Your Specimens in Order: The Importance of Individualized Test Orders and Timely Test Utilization

Get Your Specimens in Order: The Importance of Individualized Test Orders and Timely Test Utilization Get Your Specimens in Order: The Importance of Individualized Test Orders and Timely Test Utilization Prepared and presented by Jennifer Bolen, JD Disclosures for Jennifer Bolen, JD Consultant - Generation

More information

Laboratory Service Report

Laboratory Service Report 4 05/25/19 Client C702884-DLP ROCHESTER Amphetamines, Confirmation Positive Confirmed POSITIVE by LC-S/S for the following: Amphetamine = 52 ethamphetamine = 124 ethamphetamine exists in the d- and l-isomeric

More information

10/9/18. Learning Objectives. Get Your Specimens in Order: The Importance of Individualized Test Orders and Timely Test Utilization

10/9/18. Learning Objectives. Get Your Specimens in Order: The Importance of Individualized Test Orders and Timely Test Utilization Get Your Specimens in Order: The Importance of Individualized Test Orders and Timely Test Utilization Prepared and presented by Jennifer Bolen, JD Disclosures for Jennifer Bolen, JD Consultant - Generation

More information

Drugs of Abuse I Serum

Drugs of Abuse I Serum Drugs of Abuse I Serum 2017-11 1.10 For quality monitoring of quantitative measurements by chromatographic methods These reference materials are produced on the basis of human matrices. The highly accurate

More information

Laboratory Testing to Support Pain Management: Methods, Concepts and Case Studies

Laboratory Testing to Support Pain Management: Methods, Concepts and Case Studies Laboratory Testing to Support Pain Management: Methods, Concepts and Case Studies Frederick G. Strathmann, PhD, DABCC, (CC,TC) Medical Director, Toxicology Associate Scientific Director of MS ARUP Laboratories

More information

Urine Drug Testing Methods 3-5

Urine Drug Testing Methods 3-5 Urine Drug Testing Methods 3-5 Type of Test Logistics Pearls Initial Screening Test: Immunoassay Confirmatory Test: Gas chromatography-mass spectrometry (GCMS) + or Liquid chromatography-mass spectrometry

More information

[ APPLICATION NOTE ] APPLICATION BENEFITS INTRODUCTION WATERS SOLUTIONS KEYWORDS

[ APPLICATION NOTE ] APPLICATION BENEFITS INTRODUCTION WATERS SOLUTIONS KEYWORDS A Comprehensive Method for the Analysis of Pain Management Drugs and Drugs of Abuse Incorporating Simplified, Rapid Mixed-Mode SPE with UPLC-MS/MS for Clinical Research Jonathan P. Danaceau, Scott Freeto,

More information

Toxicology Practice and Procedure Handbook

Toxicology Practice and Procedure Handbook Toxicology Practice and Procedure Handbook Table of Contents Welcome Letter...3 Lab Requisition Protocol...4 Urine Collection and Shipment Protocol...5 Drug Confirmation Composite Profiles...8 Drug and

More information

ORAL FLUID AS A CHEMICAL TEST FOR THE DRE PROGRAM : HISTORY, THE FUTURE, AND PRACTICAL CONSIDERATIONS

ORAL FLUID AS A CHEMICAL TEST FOR THE DRE PROGRAM : HISTORY, THE FUTURE, AND PRACTICAL CONSIDERATIONS ORAL FLUID AS A CHEMICAL TEST FOR THE DRE PROGRAM : HISTORY, THE FUTURE, AND PRACTICAL CONSIDERATIONS Barry K Logan PhD, DABFT National Director of Forensic Services, NMS Labs Willow Grove PA Disclaimer

More information

LC Application Note. Dangerous driver?

LC Application Note. Dangerous driver? LC Application Note Dangerous driver? www.palsystem.com Dangerous driver? Robert M. Sears 1 ; Kenneth C. Lewis 2 ; and Kim Gamble 3 1 SC Law Enforcement Division, Columbia, SC 29221; 2 OpAns LLC, Durham

More information

INTERPATH LABORATORY, INC. TEST UPDATES

INTERPATH LABORATORY, INC. TEST UPDATES EFFECTIVE DATE: February 16, 2016 INTERPATH LABORATORY, INC. TEST UPDATES Please take note of the following test updates and make the appropriate changes in your Interpath Service Manual. Feel free to

More information

Jonathan Rochon, Pier-Luc Plante, Serge Auger, Réal Paquin, Jacques Corbeil, Pierre Picard

Jonathan Rochon, Pier-Luc Plante, Serge Auger, Réal Paquin, Jacques Corbeil, Pierre Picard Dried Blood Spots in Tips Targeted Drug Screening in 9 Seconds per Sample Using Laser Diode Thermal Desorption Mass Spectrometry (LDTD-MS/MS) Jonathan Rochon, Pier-Luc Plante, Serge Auger, Réal Paquin,

More information

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK Schedule of ccreditation United Kingdom ccreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK ccredited to Laboratory locations: Gavenny Court Brecon Road bergavenny Monmouthshire

More information

Fully Automated Online Sample Preparation and LC-MS/MS Analysis of Drugs of Abuse in Oral Fluids

Fully Automated Online Sample Preparation and LC-MS/MS Analysis of Drugs of Abuse in Oral Fluids PO-CON1753E Fully Automated Online Sample Preparation and LC-MS/MS Analysis of Drugs of Abuse in Oral Fluids ASMS 2017 TP-442 Joshua F. Emory 1, Nathan DeFreitas 2, Michael Roberts 1, Manoj Tyagi 2, M.

More information

Urine drug testing it s not always crystal clear

Urine drug testing it s not always crystal clear Urine drug testing it s not always crystal clear Kirk Moberg, MD, PhD, FASAM Executive Medical Director, UnityPoint Health Illinois Institute for Addiction Recovery Clinical Professor of Internal Medicine

More information

Validation of an Automated Method to Remove

Validation of an Automated Method to Remove Shahana Wahab Huq 1, Richard Thomas 2, Agnes Cua 2, Seyed Sadjadi 1 1 Phenomenex, 411 Madrid Avenue, Torrance, CA 951 2 Precision Toxicology, 33 Bunker Hill Street, San Diego, CA 9219 Validation of an

More information

Ultra-Fast Forensic Toxicological Screening and Quantitation under 3 Minutes using SCIEX X500R QTOF System and SCIEX OS 1.

Ultra-Fast Forensic Toxicological Screening and Quantitation under 3 Minutes using SCIEX X500R QTOF System and SCIEX OS 1. Ultra-Fast Forensic Toxicological Screening and Quantitation under 3 Minutes using SCIEX X500R QTOF System and SCIEX OS 1.0 Software Xiang He 1, Adrian M. Taylor 2, Michael Jarvis 2 and Alexandre Wang

More information

Evaluation of the Impact of Expanding ELISA Screening in DUID Investigations. Aileen Lu*, Karen S. Scott, Aya Chan-Hosokawa, and Barry K.

Evaluation of the Impact of Expanding ELISA Screening in DUID Investigations. Aileen Lu*, Karen S. Scott, Aya Chan-Hosokawa, and Barry K. Evaluation of the Impact of Expanding ELISA Screening in DUID Investigations Aileen Lu*, Karen S. Scott, Aya Chan-Hosokawa, and Barry K. Logan FSF Emerging Forensic Scientist Award Oral Presentation Disclosure

More information

Drugs Found in Medical Examiner Cases

Drugs Found in Medical Examiner Cases s Found in Medical Examiner Cases 1,1 difluoroethane propellant in aerosols 10-Hydroxycarbazepine 11-Hydroxy Delta-9 THC 6-monoacetylmorphine 7-amino clonazepam acetaminophen acetone alpha-hydroxyalprazolam

More information

Rapid LC/TOF MS for Analytical Screening of Drugs in the Clinical Research Lab

Rapid LC/TOF MS for Analytical Screening of Drugs in the Clinical Research Lab Application Note Clinical Research Rapid LC/TOF MS for Analytical Screening of Drugs in the Clinical Research Lab Authors Adam Barker 1,2, Frederick G. Strathmann 3, Natalie N. Rasmussen 4, and Carrie

More information

INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE, MARYLAND QUARTERLY REPORT: FOURTH QUARTER, 2008 AND 2008 SUMMARY

INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE, MARYLAND QUARTERLY REPORT: FOURTH QUARTER, 2008 AND 2008 SUMMARY INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE, MARYLAND QUARTERLY REPORT: FOURTH QUARTER, 2008 AND 2008 SUMMARY A report from the Office of Epidemiology and Planning Baltimore

More information

2015 Annual Physician Notice

2015 Annual Physician Notice 0 Annual Physician Notice The Office of Inspector General (OIG) recommends clinical laboratories send notices to physicians and other providers who use their services, at least once a year, to inform the

More information

ChemaTox Blood Drug Testing Matrix (Updated May 24th, 2016)

ChemaTox Blood Drug Testing Matrix (Updated May 24th, 2016) ChemaTox Blood Drug Testing Matrix (Updated May 24th, 2016) Email: DREtox@chematox.com; Phone: (303)440-4500 Always identify any medications/drugs the suspect states they have taken, or that you suspect

More information

Tests recently added to the NMS Labs test menu. New Tests are effective immediately.

Tests recently added to the NMS Labs test menu. New Tests are effective immediately. Modified Date: 01/12/2012 In our continuing effort to provide you with the highest quality toxicology laboratory services available, we have compiled important changes regarding a number of tests we perform.

More information

Linking Opioid Treatment in Primary Care. Roxanne Lewin M.D.

Linking Opioid Treatment in Primary Care. Roxanne Lewin M.D. Roxanne Lewin M.D. The Facts Fewer than 10 percent of individuals with an alcohol use disorder and only about 20 percent of individuals with an opioid use disorder receive specialty treatment. Many individuals

More information

May Revised Urine Drug Screen Test Menu Effective mid-june Lauren Anthony, MD, MT(ASCP) SBB Medical Director, Allina Health Laboratory

May Revised Urine Drug Screen Test Menu Effective mid-june Lauren Anthony, MD, MT(ASCP) SBB Medical Director, Allina Health Laboratory May 2014 Lauren Anthony, MD, MT(ASCP) SBB Medical Director, Allina Health Laboratory Revised Urine Drug Test Menu Effective mid-june 2014 To better address the complexities of drug screening for different

More information

Proof of Concept for Automated SPE/HPLC/MS/MS Methods to Replace Traditional Immunoassay with MS Confirmation of Driving Under the Influence Samples

Proof of Concept for Automated SPE/HPLC/MS/MS Methods to Replace Traditional Immunoassay with MS Confirmation of Driving Under the Influence Samples Proof of Concept for Automated SPE/HPLC/MS/MS Methods to Replace Traditional Immunoassay with MS Confirmation of Driving Under the Influence Samples Robert M. Sears, Toxicology Technical Leader 1, Kenneth

More information

CDIA TM Marijuana Colloidal Gold Test Cassette (Saliva)

CDIA TM Marijuana Colloidal Gold Test Cassette (Saliva) CDIA TM Marijuana Colloidal Gold Test Cassette (Saliva) Cat. No.: DTSJZ023 Pkg. Size: Intended Use The CDIA TM Marijuana Colloidal Gold Test Cassette (Saliva) is an immunochromatography based one step

More information

A Simple and Accurate Method for the Rapid Quantitation of Drugs of Abuse in Urine Using Liquid Chromatography

A Simple and Accurate Method for the Rapid Quantitation of Drugs of Abuse in Urine Using Liquid Chromatography Application Note LCMS-109 A Simple and Accurate Method for the Rapid Quantitation of Drugs of Abuse in Urine Using Liquid Chromatography Time of Flight (LC-TOF) Mass Spectrometry Introduction Many clinical

More information

Applications of High Resolution Mass Spectrometry in Forensic Toxicology. Patrick Kyle, PhD.

Applications of High Resolution Mass Spectrometry in Forensic Toxicology. Patrick Kyle, PhD. Applications of High Resolution Mass Spectrometry in Forensic Toxicology Patrick Kyle, PhD pkyle@umc.edu Financial Disclosures Grant/Research Support: None Salary/Consultant Fees: None Board/Committee/Advisory

More information

Frequently Asked Questions: Opiate Dependency and Methadone Maintenance Treatment program follow-up

Frequently Asked Questions: Opiate Dependency and Methadone Maintenance Treatment program follow-up Frequently Asked Questions: Opiate Dependency and Methadone Maintenance Treatment program follow-up Dr. Bhushan M. Kapur Associate Professor Department of Laboratory Medicine and Pathobiology, Faculty

More information

INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE CITY

INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE CITY 2009 FINAL REPORT INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE CITY This report was prepared by: Dr. Jose Arbelaez, M.D. of Baltimore Substance Abuse Systems, and Ryan J. Petteway,

More information

Pain Medication Management Program Monitors Patient Compliance

Pain Medication Management Program Monitors Patient Compliance PeaceHealth Laboratories UPDATE 2014/15 Edition Pain Medication Management Program Monitors Patient Compliance BENEFITS Monitors analgesic medication adherence to ensure patient safety and protect your

More information

Cross-reactivity reactivity in EMIT

Cross-reactivity reactivity in EMIT Blood Drug Analysis at the State Bureau of Investigation Crime Laboratory Richard W. Waggoner, Jr. Sample Requirements 2-10 ml gray top vacutainers At least 10 ml of urine sample for drug facilitated sexual

More information

Validation Report for the Neogen Fentanyl Kit for ELISA Screening of Whole Blood and Urine Specimens

Validation Report for the Neogen Fentanyl Kit for ELISA Screening of Whole Blood and Urine Specimens Validation Report for the Neogen Fentanyl Kit for ELISA Screening of Whole Blood and Urine Specimens This document describes the validation of a Neogen Fentanyl kit for the semi-quantitative analysis of

More information

Test Definition: PDSOX Pain Clinic Drug Screen, Chain of Custody, Urine

Test Definition: PDSOX Pain Clinic Drug Screen, Chain of Custody, Urine Reporting Title: Pain Clinic Drug Screen, CoC, U Performing Location: Rochester Specimen Requirements: Container/Tube: Chain-of-Custody Kit (Supply T282) containing the specimen containers, seals, and

More information

Prescription Drug Monitoring Reference Guide: 2017

Prescription Drug Monitoring Reference Guide: 2017 Prescription Drug Monitoring Reference Guide: 2017 Prescription Drug Monitoring Test Codes Test Codes Drug/Drug Class P P,D,M P,D D,M D Alcohol Metabolites 90079 16910 92142 16217 Amphetamines 92222 70245

More information

Welcome - SAMHSA s Role. Welcome SAMHSA Key Messages 4. Welcome SAMHSA s Direction

Welcome - SAMHSA s Role. Welcome SAMHSA Key Messages 4. Welcome SAMHSA s Direction Welcome - SAMHSA s Role 2 Welcome and Opening Remarks The National Conference on Substance Abuse, Child Welfare and the Courts Division of Workplace Programs Ron R. Flegel, BSMT, M.S. and Charles Lodico,

More information

Pain Medication Management Program Supports Patient Outcomes and Adherence

Pain Medication Management Program Supports Patient Outcomes and Adherence PeaceHealth Laboratories UPDATE 2015 Revised Edition Pain Medication Management Program Supports Patient Outcomes and Adherence BENEFITS Monitors analgesic medication adherence to ensure patient safety

More information

Test Definition: PCDSO Pain Clinic Drug Screen, Urine

Test Definition: PCDSO Pain Clinic Drug Screen, Urine Reporting Title: Pain Clinic Drug Screen, U Performing Location: Rochester Specimen Requirements: Collection Container/Tube: Plastic urine container Submission Container/Tube: Plastic, 60-mL urine bottle

More information

What Your Drug Test Really Means. Krista Beiermann, RN, OHS Occupational Health Services, Columbus Hospital

What Your Drug Test Really Means. Krista Beiermann, RN, OHS Occupational Health Services, Columbus Hospital What Your Drug Test Really Means Krista Beiermann, RN, OHS Occupational Health Services, Columbus Hospital Disclosure There are no relevant financial relationships with commercial interests associated.

More information

A Comprehensive Screening of Illicit and Pain Management Drugs from Whole Blood Using SPE and LC/MS/MS

A Comprehensive Screening of Illicit and Pain Management Drugs from Whole Blood Using SPE and LC/MS/MS A Comprehensive Screening of Illicit and Pain Management Drugs from Whole Blood Using SPE and LC/MS/MS Introduction Drug analysis from whole blood is gaining popularity due to a more complete measurement

More information

European Guidelines for Workplace Drug Testing in UrineandOral fluid

European Guidelines for Workplace Drug Testing in UrineandOral fluid EWDTS European Workplace Drug Testing Society European Guidelines for Workplace Drug Testing in UrineandOral fluid 9th EWDTS Symposium in Lisbon Sanna Taskinen Michaela Neuhofer Updating project # 2 Current

More information

Substances under Surveillance

Substances under Surveillance Substances under Surveillance The following substances are under surveillance by the World Health Organization (WHO) as they are considered to have the potential to cause public health harm. For ease of

More information

10/16/2017. Objectives. Drug Testing Interpretation in Addiction Care. Background. Which is Nonadherent?

10/16/2017. Objectives. Drug Testing Interpretation in Addiction Care. Background. Which is Nonadherent? Objectives Drug Testing Interpretation in Addiction Care Brandi Puet, Pharm.D. Describe the difference between immunoassay and confirmatory testing. List explanations for unexpected negative or positive

More information

E XCEL LENCE JUST GOT BETTER UCT FORENSICS CLEAN SCREEN XCEL SPE COLUMNS

E XCEL LENCE JUST GOT BETTER UCT FORENSICS CLEAN SCREEN XCEL SPE COLUMNS FORENSICS UCT E XCEL LENCE JUST GOT BETTER CLEAN SCREEN XCEL SPE COLUMNS CLEAN SCREEN XCEL COLUMNS EXTRACTION OF BASIC DRUGS AND METABOLITES FROM URINE/ BLOOD USING SPE CARTRIDGES 130mg Clean Screen Xcel

More information

METHAMPHETAMINE & AMPHETAMINE

METHAMPHETAMINE & AMPHETAMINE METHAMPHETAMINE & AMPHETAMINE Enantiomers from Urine Rapid and Accurate Chiral Separation Polysaccharide Chiral Chiral LC LC Columns and SFC PHEN-RUO-49 Revision: Lux 3 µm AMP Column High Efficiency LC/MS/MS

More information

Comparison of Different Whole Blood Sample Pretreatment Methods for Targeted Analysis of Basic Drugs

Comparison of Different Whole Blood Sample Pretreatment Methods for Targeted Analysis of Basic Drugs Seyed Sadjadi, Shahana Huq, Sean Orlowicz and Laura Snow Phenomenex, Inc., 411 Madrid Ave., Torrance, CA 90501 USA Comparison of Different Whole Blood Sample Pretreatment Methods for Targeted Analysis

More information

Does ultram show up as an opiate

Does ultram show up as an opiate Search Does ultram show up as an opiate Tramadol ( Ultram ) is prescribed for treating moderate to severe pain in adults. 19-2-2018 I took Tramadol Hydrochloride for 6 months due to joint pain from my

More information

Urine Drug Screening: The Essentials of Interpretation

Urine Drug Screening: The Essentials of Interpretation Urine Drug Screening: The Essentials of Interpretation Loralie J Langman, PhD DABCC (CC, MD, TC), F-ABFT Director Clinical and Forensic Toxicology Laboratory, Mayo Clinic Professor, Mayo Clinic College

More information

MEDICAL POLICY Drug Testing

MEDICAL POLICY Drug Testing POLICY: PG0069 ORIGINAL EFFECTIVE: 01/01/11 LAST REVIEW: 11/13/18 MEDICAL POLICY Drug Testing GUIDELINES This policy does not certify benefits or authorization of benefits, which is designated by each

More information

TITLE: Guidelines for Treatment of Chronic Pain EFFECTIVE DATE: LAST REVISED DATE: LAST REVIEWED DATE:

TITLE: Guidelines for Treatment of Chronic Pain EFFECTIVE DATE: LAST REVISED DATE: LAST REVIEWED DATE: TITLE: Guidelines for Treatment of Chronic Pain EFFECTIVE DATE: 4.19.16 LAST REVISED DATE: 4.19.16 LAST REVIEWED DATE: 4.19.16 Table of Contents 1. How do I conduct my first few visits with a patient who

More information

European Guidelines for Workplace Drug Testing in Blood and Blood Spots

European Guidelines for Workplace Drug Testing in Blood and Blood Spots EWDTS European Workplace Drug Testing Society European Guidelines for Workplace Drug Testing in Blood and Blood Spots 9th EWDTS Symposium in Lisbon Wim Schielen 29-5-2015, Lisbon Updating project # 2 Current

More information

Prepared by Date Adopted Supersedes Procedure # Review Date Revision Date Signature. Distributed to # of Copies Distributed to # of Copies

Prepared by Date Adopted Supersedes Procedure # Review Date Revision Date Signature. Distributed to # of Copies Distributed to # of Copies Procedure: Status DS Prepared by Date Adopted Supersedes Procedure # Review Date Revision Date Signature Distributed to # of Copies Distributed to # of Copies PRINCIPLE: The Status DS 10 Panel (MET/OPI/COC/THC/PCP/BZO/BAR/MTD/TCA/AMP)

More information

Community Drug Early Warning System (CDEWS-3): Washington, DC - Site 3 of 4

Community Drug Early Warning System (CDEWS-3): Washington, DC - Site 3 of 4 Community Drug Early Warning System (CDEWS-3): Washington, DC - Site 3 of 4 Office of National Drug Control Policy Executive Office of the President May 2017 ACKNOWLEDGMENTS This report was funded by Cooperative

More information

1. Amphetamine (Adderall, desoxyn, Dexedrine,dextrostat, spancap, oxydess II)

1. Amphetamine (Adderall, desoxyn, Dexedrine,dextrostat, spancap, oxydess II) Cross reactivity of various pharmaceuticals against the Drugs of Abuse Screening Panel (posted 2/3/09) The following tables are only applicable to the specific analyzer and reagents used at HRHS main lab.

More information

DrugSmartCup & DrugSmartDip Accuracy Report as produced by Ameditech, Inc.

DrugSmartCup & DrugSmartDip Accuracy Report as produced by Ameditech, Inc. Accuracy The accuracy of the DrugSmart Drugs of Abuse Tests was evaluated in comparison to commercially available drug screen tests. Sixty (60) negative urine samples collected from presumed non-user volunteers

More information

Your Results are Our Priority.

Your Results are Our Priority. Your Results are Our Priority. Enzyme Linked Immunosorbent Assay (ELISA) One year shelf life Ready to use, color coded reagents and bottles Single dilution factor Adaptable for all forensic matrices Forensic

More information

Toxicology 101. Arizona Problem Solving Courts April 25, 2016

Toxicology 101. Arizona Problem Solving Courts April 25, 2016 Toxicology 101 Arizona Problem Solving Courts April 25, 2016 Aaron Brown, Ph.D. Technical Group Lead Norchem Drug Testing Laboratory Cordant Health Solutions Flagstaff, Arizona Toxicology Toxicology is

More information

Controlled Substance Monitoring in the Age of the Opioid Epidemic

Controlled Substance Monitoring in the Age of the Opioid Epidemic Controlled Substance Monitoring in the Age of the Opioid Epidemic Paul E. Hilliard, MS, MD Hospital Pain Committee Chair Department of Anesthesiology CME housekeeping I have no financial disclosures AKA,

More information

EDUCATIONAL COMMENTARY rd TEST EVENT Chemistry Urine Drug Testing

EDUCATIONAL COMMENTARY rd TEST EVENT Chemistry Urine Drug Testing EDUCATIONAL COMMENTARY 2003 3 rd TEST EVENT Chemistry Urine Drug Testing Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE

More information

MEDICAL POLICY Drug Testing

MEDICAL POLICY Drug Testing POLICY: PG0069 ORIGINAL EFFECTIVE: 01/01/11 LAST REVIEW: 04/10/18 MEDICAL POLICY Drug Testing GUIDELINES This policy does not certify benefits or authorization of benefits, which is designated by each

More information

Testing for Controlled Substances

Testing for Controlled Substances Testing for illicit drugs Testing for Controlled Substances 1 Purposes: Employment Sports Screening medical eval. Legal Monitoring Treatment Probation Prescribing controlled substances Forensics 2 Drug

More information

Detection of Neonatal Drug Exposure Using Umbilical Cord Tissue and Liquid Chromatography Time-of-Flight Mass Spectrometry

Detection of Neonatal Drug Exposure Using Umbilical Cord Tissue and Liquid Chromatography Time-of-Flight Mass Spectrometry ORIGINAL ARTICLE Detection of Neonatal Drug Exposure Using Umbilical Cord Tissue and Liquid Chromatography Time-of-Flight Mass Spectrometry Stephanie J. Marin, PhD,* Anna Metcalf, BS, Matthew D. Krasowski,

More information

Validation of a Benzodiazepine and Z-Drug Method Using an Agilent 6430 LC/MS/MS

Validation of a Benzodiazepine and Z-Drug Method Using an Agilent 6430 LC/MS/MS Validation of a Benzodiazepine and Z-Drug Method Using an Agilent 6430 LC/MS/MS Application Note Forensics Authors Jason Hudson, Ph.D., James Hutchings, Ph.D., and Rebecca Wagner, Ph.D. Virginia Department

More information

Welcome! Supreme Court of Ohio Specialized Dockets Conference. October 23-24, 2017

Welcome! Supreme Court of Ohio Specialized Dockets Conference. October 23-24, 2017 Welcome! Supreme Court of Ohio Specialized Dockets Conference October 23-24, 2017 Drug Testing: Do you know enough to be dangerous? Presented by William L. Parker President & CEO American Court & Drug

More information

Drug Adherence Assessment Report

Drug Adherence Assessment Report Collection Date: 11:13 AM Gender: Female Received in Lab: 12:13 PM CT Prescribed Medications: Drug Adherence Assessment Report ACTIQ, ADDERALL, AMITRIPTYLINE, BUTRANS, CYCLOBENZAPRINE, CYMBALTA, EFFEXOR,

More information

A substance that reduces pain and may or may not have psychoactive properties.

A substance that reduces pain and may or may not have psychoactive properties. GLOSSARY OF TERMS AMPHETAMINE-TYPE STIMULANTS (ATS) A group of substances, mostly synthetic, with closely related chemical structure which have, to varying degrees, a stimulating effect on the central

More information

DOF. Scheme Description. Drugs in Oral Fluid Scheme

DOF. Scheme Description. Drugs in Oral Fluid Scheme DOF Drugs in Oral Fluid Scheme Scheme Description LGC Standards Proficiency Testing 1 Chamberhall Business Park Chamberhall Green Bury Lancashire BL9 0AP United Kingdom Telephone: +44 (0) 161 762 2500

More information

MEDICAL POLICY No R2 DRUG TESTING

MEDICAL POLICY No R2 DRUG TESTING Summary of Changes MEDICAL POLICY DRUG TESTING Effective Date: April 10, 2017 Review Dates: 5/15, 5/16, 11/16, 2/17 Date Of Origin: May 13, 2015 Status: Current Clarifications: Deletions: Additions: Pg.

More information

PAIN PANEL. Research and Solutions

PAIN PANEL. Research and Solutions PAIN PANEL Research and Solutions Pain management drug use and abuse has increased significantly in recent years. The 21 National Survey on Drug Use & Health (NSDUH) reports that 17.3% of first-time drug

More information

Annual Reports Questionnaire (ARQ) Part III: Extent, patterns and trends in drug use

Annual Reports Questionnaire (ARQ) Part III: Extent, patterns and trends in drug use Annual Reports Questionnaire (ARQ) Part III: Extent, patterns and trends in drug use Report of the Government of: Reporting Year: Completed on (date): Please return completed questionnaire to: arq@unodc.org

More information

Drug Testing Basics. by Erowid

Drug Testing Basics. by Erowid Drug Testing Basics by Erowid INDEX 1. What do they Test for? 2. Test Types 3. Test Sensitivity 4. Detection Periods WHAT DO THEY TEST FOR? The first thing to know about drug testing is what the standard

More information

ToxCup Drug Screen Cup Step-by Step Instructions

ToxCup Drug Screen Cup Step-by Step Instructions ToxCup Drug Screen Cup Step-by Step Instructions This is a preliminary screening test that detects drug-of-abuse in urine at specified detection levels. To confirm preliminary positive results, a more

More information

DRUGS OF ABUSE TEST CUPS 14-DRUG PANEL WITH ADULTERANTS Step by Step Instructions

DRUGS OF ABUSE TEST CUPS 14-DRUG PANEL WITH ADULTERANTS Step by Step Instructions DRUGS OF ABUSE TEST CUPS 14-DRUG PANEL WITH ADULTERANTS Step by Step Instructions For in vitro diagnostic use The McKesson Consult Drugs of Abuse Test Cup is a screening test for the rapid qualitative

More information

9/5/2011. Outline. 1. Past and Current Trends re: RX Abuse 2. Diversion Methods 3. Regulatory Reporting Requirements 4. Q/A

9/5/2011. Outline. 1. Past and Current Trends re: RX Abuse 2. Diversion Methods 3. Regulatory Reporting Requirements 4. Q/A Prescription Drug Abuse Crises Outline 1. Past and Current Trends re: RX Abuse 2. Diversion Methods 3. Regulatory Reporting Requirements 4. Q/A 1 1970s 1980s 2 The 1990s OXYCODONE Oxycodone/APAP OxyContin

More information

Lyndsey Knoy, D-ABFT-FT Forensic Scientist Washington State Toxicology Laboratory.

Lyndsey Knoy, D-ABFT-FT Forensic Scientist Washington State Toxicology Laboratory. Lyndsey Knoy, D-ABFT-FT Forensic Scientist Washington State Toxicology Laboratory Lyndsey.Knoy@wsp.wa.gov Forensic Toxicology is an interdisciplinary science that analyzes blood, fluid and/or tissues for

More information

Urine Drug Testing to Monitor Opioid Use In Managing Chronic Pain

Urine Drug Testing to Monitor Opioid Use In Managing Chronic Pain Faculty Disclosure Henry C. Nipper, PhD, DABCC Dr. Nipper has listed no financial interest/arrangement that would be considered a conflict of interest. Urine Drug Testing to Monitor Opioid Use In Managing

More information

Bree Collaborative AMDG Opioid Prescribing Guidelines Workgroup. Opioid Prescribing Metrics - DRAFT

Bree Collaborative AMDG Opioid Prescribing Guidelines Workgroup. Opioid Prescribing Metrics - DRAFT Bree Collaborative AMDG Opioid Prescribing Guidelines Workgroup Opioid Prescribing Metrics - DRAFT Definitions: Days Supply: The total of all opioid prescriptions dispensed during the calendar quarter

More information

APPLICATION TN Rapid Analysis of a 48 Drug Research Panel in Less Than 4 Minutes Using Kinetex Biphenyl Core-Shell Technology HPLC/UHPLC Columns

APPLICATION TN Rapid Analysis of a 48 Drug Research Panel in Less Than 4 Minutes Using Kinetex Biphenyl Core-Shell Technology HPLC/UHPLC Columns APPLICATION Rapid Analysis of a 48 Drug Research Panel in Less Than 4 Minutes Using Kinetex Biphenyl Core-Shell Technology HPLC/UHPLC Columns Sean Orlowicz Manager, PhenoLogix When not in the lab, Sean

More information

2012 DRUG RELATED DEATH STATISTICS JANUARY 1, 2012 THROUGH DECEMBER 31, 2012

2012 DRUG RELATED DEATH STATISTICS JANUARY 1, 2012 THROUGH DECEMBER 31, 2012 JANUARY 1, 2012 THROUGH DECEMBER 31, 2012 All deaths counted in the column labeled ACCIDENTAL OVERDOSE were the direct result of the drugs ingested by the decedent. The drugs noted as being present came

More information

Payment Policy: Urine Specimen Validity Testing Reference Number: CC.PP.056 Product Types: ALL Effective Date: 11/01/2017 Last Review Date:

Payment Policy: Urine Specimen Validity Testing Reference Number: CC.PP.056 Product Types: ALL Effective Date: 11/01/2017 Last Review Date: Payment Policy: Reference Number: CC.PP.056 Product Types: ALL Effective Date: 11/01/2017 Last Review Date: Coding Implications Revision Log See Important Reminder at the end of this policy for important

More information

C O P E. Milwaukee County Opioid-Related Overdose Report MILWAUKEE COMMUNITY OPIOID PREVENTION EFFORT

C O P E. Milwaukee County Opioid-Related Overdose Report MILWAUKEE COMMUNITY OPIOID PREVENTION EFFORT Milwaukee County Opioid-Related Overdose Report 2012 2016 MILWAUKEE C O P E COMMUNITY OPIOID PREVENTION EFFORT For additional information or if you have questions about the data presented in this report,

More information

Product Catalog. February We are Toxicology. Tel Toll Free Fax

Product Catalog. February We are Toxicology. Tel Toll Free Fax Product Catalog www.immunalysis.com We are Toxicology. Tel 909.482.0840 Toll Free 888.664.8378 Fax 909.482.0850 Comprehensive Drug Testing Solutions 24 Urine HEIA Assays 13 Oral Fluid HEIA Assays 27 Oral

More information